Poston T
Pathog Dis. 2024; 82.
PMID: 39043447
PMC: 11338180.
DOI: 10.1093/femspd/ftae017.
Richardson S, Medhavi F, Tanner T, Lundy S, Omosun Y, Igietseme J
Front Immunol. 2021; 12:698737.
PMID: 34249004
PMC: 8264281.
DOI: 10.3389/fimmu.2021.698737.
Tifrea D, Pal S, Fairman J, Massari P, de la Maza L
NPJ Vaccines. 2020; 5(1):37.
PMID: 32411400
PMC: 7210953.
DOI: 10.1038/s41541-020-0182-9.
Yu H, Karunakaran K, Jiang X, Brunham R
Expert Rev Vaccines. 2016; 15(8):977-88.
PMID: 26938202
PMC: 4981183.
DOI: 10.1586/14760584.2016.1161510.
Pal S, Tatarenkova O, de la Maza L
Immunology. 2015; 146(3):432-43.
PMID: 26423798
PMC: 4610632.
DOI: 10.1111/imm.12520.
A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigs.
Boje S, Olsen A, Erneholm K, Agerholm J, Jungersen G, Andersen P
Immunol Cell Biol. 2015; 94(2):185-95.
PMID: 26268662
PMC: 4748142.
DOI: 10.1038/icb.2015.79.
Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice.
Yu H, Karunakaran K, Jiang X, Brunham R
Vaccine. 2014; 32(36):4672-80.
PMID: 24992718
PMC: 4148050.
DOI: 10.1016/j.vaccine.2014.06.002.
Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum.
Tifrea D, Pal S, Popot J, Cocco M, de la Maza L
J Immunol. 2014; 192(11):5201-13.
PMID: 24778450
PMC: 4030638.
DOI: 10.4049/jimmunol.1303392.
Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.
Vasilevsky S, Greub G, Nardelli-Haefliger D, Baud D
Clin Microbiol Rev. 2014; 27(2):346-70.
PMID: 24696438
PMC: 3993100.
DOI: 10.1128/CMR.00105-13.
Assessment of the role in protection and pathogenesis of the Chlamydia muridarum V-type ATP synthase subunit A (AtpA) (TC0582).
Cheng C, Jain P, Pal S, Tifrea D, Sun G, Teng A
Microbes Infect. 2013; 16(2):123-133.
PMID: 24161793
PMC: 3946604.
DOI: 10.1016/j.micinf.2013.10.012.
Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.
Tifrea D, Ralli-Jain P, Pal S, de la Maza L
Infect Immun. 2013; 81(5):1741-50.
PMID: 23478318
PMC: 3648024.
DOI: 10.1128/IAI.00734-12.
Chlamydia trachomatis control requires a vaccine.
Brunham R, Rappuoli R
Vaccine. 2013; 31(15):1892-7.
PMID: 23375977
PMC: 4148049.
DOI: 10.1016/j.vaccine.2013.01.024.
Proteomic identification of immunodominant chlamydial antigens in a mouse model.
Teng A, Cruz-Fisher M, Cheng C, Pal S, Sun G, Ralli-Jain P
J Proteomics. 2012; 77:176-86.
PMID: 22959960
PMC: 3575745.
DOI: 10.1016/j.jprot.2012.08.017.
T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.
Yang X, Brunham R
Can J Infect Dis. 2012; 9(2):99-108.
PMID: 22451777
PMC: 3307538.
DOI: 10.1155/1998/395297.
Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice.
Yu H, Karunakaran K, Jiang X, Shen C, Andersen P, Brunham R
Infect Immun. 2012; 80(4):1510-8.
PMID: 22290151
PMC: 3318408.
DOI: 10.1128/IAI.06338-11.
Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine.
Carmichael J, Pal S, Tifrea D, de la Maza L
Vaccine. 2011; 29(32):5276-83.
PMID: 21609745
PMC: 3139009.
DOI: 10.1016/j.vaccine.2011.05.013.
Amphipols stabilize the Chlamydia major outer membrane protein and enhance its protective ability as a vaccine.
Tifrea D, Sun G, Pal S, Zardeneta G, Cocco M, Popot J
Vaccine. 2011; 29(28):4623-31.
PMID: 21550371
PMC: 3114171.
DOI: 10.1016/j.vaccine.2011.04.065.
Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells.
Yu H, Karunakaran K, Kelly I, Shen C, Jiang X, Foster L
J Immunol. 2011; 186(6):3615-21.
PMID: 21296978
PMC: 3072838.
DOI: 10.4049/jimmunol.1002952.
Identification of immunodominant antigens by probing a whole Chlamydia trachomatis open reading frame proteome microarray using sera from immunized mice.
Cruz-Fisher M, Cheng C, Sun G, Pal S, Teng A, Molina D
Infect Immun. 2010; 79(1):246-57.
PMID: 20956570
PMC: 3019893.
DOI: 10.1128/IAI.00626-10.
Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.
Ralli-Jain P, Tifrea D, Cheng C, Pal S, de la Maza L
Vaccine. 2010; 28(48):7659-66.
PMID: 20875490
PMC: 2981640.
DOI: 10.1016/j.vaccine.2010.09.040.
